Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX
Clinical trial NCT01039688 · COMPLETED
Trial details
- NCT number
- NCT01039688
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2013-03-01
- Enrollment
- 956
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.